Genedrive PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,522.00
4,238.00
4,928.00
1,114.00
5,129.00
3,529
Total Accounts Receivable
2,173.00
2,387.00
2,510.00
3,264.00
2,457.00
1,271
Inventories
-
-
163.00
202.00
444.00
171
Other Current Assets
195.00
212.00
366.00
290.00
410.00
432
Total Current Assets
8,890.00
6,837.00
7,967.00
4,870.00
8,440.00
5,403
Net Property, Plant & Equipment
710.00
840.00
805.00
713.00
568.00
165
Intangible Assets
3,495.00
6,785.00
7,191.00
6,273.00
3,038.00
-
Total Assets
14,072.00
14,616.00
15,993.00
11,856.00
12,046.00
5,908
Accounts Payable
751.00
522.00
696.00
914.00
816.00
Other Current Liabilities
1,266.00
3,230.00
1,727.00
948.00
1,340.00
Total Current Liabilities
2,017.00
3,752.00
2,423.00
1,862.00
2,156.00
Long-Term Debt
-
-
4,025.00
4,991.00
5,199.00
Deferred Taxes
977.00
154.00
30.00
-
-
Other Liabilities
-
-
-
1,250.00
1,250.00
Total Liabilities
2,017.00
3,752.00
6,448.00
8,103.00
8,605.00
Common Equity (Total)
12,055.00
10,864.00
9,545.00
3,753.00
3,441.00
Total Shareholders' Equity
12,055.00
10,864.00
9,545.00
3,753.00
3,441.00
Total Equity
12,055.00
10,864.00
9,545.00
3,753.00
3,441.00
Liabilities & Shareholders' Equity
14,072.00
14,616.00
15,993.00
11,856.00
12,046.00

About Genedrive

View Profile
Address
48 Grafton Street
Manchester Greater Manchester M13 9XX
United Kingdom
Employees -
Website http://epistem.co.uk
Updated 07/08/2019
Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. It operates through the following segments: Preclinical Research Services, Pharmacogenomics Services, and Diagnostics. The Preclinical Research Services segment provides pre-clinical testing services.